Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin Cloherty

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
Journal of Nephrology|May 29, 2021
Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot studyPaul Lesny, Mark Anderson, Gavin Cloherty, et al.
Tuberculosis (Edinburgh, Scotland)|June 30, 2015
Analytical and clinical performance of Abbott RealTime MTB, an assay for detection of Mycobacterium tuberculosis in pulmonary specimensNing Tang, Andrea Frank, Vihanga Pahalawatta, et al.
Journal of Virological Methods|April 22, 2014
Clinical implications of elevated HIV-1 viral load results obtained from samples stored frozen in vacutainer plasma preparation tubesGavin Cloherty, Priscilla Swanson, Danijela Lucic, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 7, 2020
Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performanceEmily Degli-Angeli, Joan Dragavon, Meei-Li Huang, et al.
The Journal of Infectious Diseases|October 20, 2022
Longitudinal Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Antibody Responses and Identification of Vaccine Breakthrough Infections Among Healthcare Workers Using Nucleocapsid Immunoglobulin GMark Anderson, Michael Stec, Amy Gosha, et al.
Scientific Reports|March 9, 2022
Evaluation of hepatitis C virus antibody assay using dried blood spot samplesVera Holzmayer, Russell Taylor, Mary C Kuhns, et al.
Journal of Clinical Microbiology|February 6, 2015
An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assayChristoph Sarrazin, Inge Dierynck, Gavin Cloherty, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 30, 2015
Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevirBart Fevery, Simone Susser, Oliver Lenz, et al.
Health Science Reports|July 9, 2026
Persistent Neurological Symptoms in Chronic Disease Patients After COVID-19 Infection in Jamaica: A Retrospective Cohort Study Exploring Clinical Manifestations of Long COVID in a Low and Middle Income CountryJacqueline P Duncan, Maria Jackson, Carol Jones Cooper, et al.
Seminars in Dialysis|December 2, 2021
Immunogenicity and tolerability of COVID-19 vaccination in peritoneal dialysis patients-A prospective observational cohort studyMichael Haase, Paul Lesny, Anja Haase-Fielitz, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Journal of Nephrology|May 29, 2021
Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot studyPaul Lesny, Mark Anderson, Gavin Cloherty, et al.
Tuberculosis (Edinburgh, Scotland)|June 30, 2015
Analytical and clinical performance of Abbott RealTime MTB, an assay for detection of Mycobacterium tuberculosis in pulmonary specimensNing Tang, Andrea Frank, Vihanga Pahalawatta, et al.
Journal of Virological Methods|April 22, 2014
Clinical implications of elevated HIV-1 viral load results obtained from samples stored frozen in vacutainer plasma preparation tubesGavin Cloherty, Priscilla Swanson, Danijela Lucic, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 7, 2020
Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performanceEmily Degli-Angeli, Joan Dragavon, Meei-Li Huang, et al.
The Journal of Infectious Diseases|October 20, 2022
Longitudinal Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Antibody Responses and Identification of Vaccine Breakthrough Infections Among Healthcare Workers Using Nucleocapsid Immunoglobulin GMark Anderson, Michael Stec, Amy Gosha, et al.
Scientific Reports|March 9, 2022
Evaluation of hepatitis C virus antibody assay using dried blood spot samplesVera Holzmayer, Russell Taylor, Mary C Kuhns, et al.
Journal of Clinical Microbiology|February 6, 2015
An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assayChristoph Sarrazin, Inge Dierynck, Gavin Cloherty, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 30, 2015
Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevirBart Fevery, Simone Susser, Oliver Lenz, et al.
Health Science Reports|July 9, 2026
Persistent Neurological Symptoms in Chronic Disease Patients After COVID-19 Infection in Jamaica: A Retrospective Cohort Study Exploring Clinical Manifestations of Long COVID in a Low and Middle Income CountryJacqueline P Duncan, Maria Jackson, Carol Jones Cooper, et al.
Seminars in Dialysis|December 2, 2021
Immunogenicity and tolerability of COVID-19 vaccination in peritoneal dialysis patients-A prospective observational cohort studyMichael Haase, Paul Lesny, Anja Haase-Fielitz, et al.
Pageof 13